Marsh & McLennan Companies (NYSE:MRSH) Price Target Raised to $201.00

Marsh & McLennan Companies (NYSE:MRSH) had its price objective hoisted by research analysts at Keefe, Bruyette & Woods from $186.00 to $201.00 in a report released on Monday, Benzinga reports. The brokerage presently has a “market perform” rating on the financial services provider’s stock. Keefe, Bruyette & Woods’ price target indicates a potential upside of 7.57% from the company’s current price.

Several other research analysts also recently commented on the company. Bank of America reduced their target price on Marsh & McLennan Companies from $179.00 to $178.00 and set an “underperform” rating for the company in a research note on Wednesday, July 15th. Mizuho dropped their price target on Marsh & McLennan Companies from $201.00 to $190.00 and set a “neutral” rating on the stock in a research note on Wednesday, October 7th. Cantor Fitzgerald increased their price target on Marsh & McLennan Companies from $212.00 to $218.00 and gave the company an “overweight” rating in a research note on Tuesday, July 21st. Morgan Stanley cut their price target on Marsh & McLennan Companies from $200.00 to $180.00 and set an “equal weight” rating for the company in a report on Tuesday, October 6th. Finally, Evercore reduced their price objective on shares of Marsh & McLennan Companies from $234.00 to $224.00 in a research report on Thursday, October 8th. Two research analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating, twelve have issued a Hold rating and two have given a Sell rating to the company. According to MarketBeat, Marsh & McLennan Companies currently has a consensus rating of “Hold” and an average target price of $203.55.

Marsh & McLennan Companies Stock Down 0.8%

Shares of MRSH stock traded down $1.50 on Monday, reaching $186.85. The stock had a trading volume of 351,347 shares, compared to its average volume of 2,807,292. Marsh & McLennan Companies has a 12 month low of $156.60 and a 12 month high of $198.49. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 1.27. The stock has a market capitalization of $89.17 billion, a price-to-earnings ratio of 22.35, a price-to-earnings-growth ratio of 2.61 and a beta of 0.59. The stock’s 50-day moving average price is $181.17.

Marsh & McLennan Companies (NYSE:MRSH) last announced its quarterly earnings results on Thursday, October 15th. The financial services provider reported $2.03 earnings per share for the quarter, topping analysts’ consensus estimates of $1.96 by $0.07. The firm had revenue of $6.86 billion for the quarter. Marsh & McLennan Companies had a return on equity of 33.32% and a net margin of 14.20%. Marsh & McLennan Companies’s revenue was up 8.1% compared to the same quarter last year. On average, sell-side analysts forecast that Marsh & McLennan Companies will post 10.45 earnings per share for the current fiscal year.

Insider Transactions at Marsh & McLennan Companies

In other news, SVP Paul Beswick sold 713 shares of the company’s stock in a transaction that occurred on Wednesday, July 29th. The stock was sold at an average price of $198.00, for a total value of $141,174.00. Following the transaction, the senior vice president owned 16,376 shares of the company’s stock, valued at approximately $3,242,448. This represents a 4.17% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Lloyd Yates sold 12,000 shares of the stock in a transaction that occurred on Thursday, July 23rd. The stock was sold at an average price of $175.65, for a total value of $2,107,800.00. Following the transaction, the director owned 12,001 shares in the company, valued at approximately $2,107,975.65. This trade represents a 50.00% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 19,813 shares of company stock worth $3,597,903 over the last quarter. Company insiders own 0.38% of the company’s stock.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in the company. BlackRock Inc. acquired a new position in shares of Marsh & McLennan Companies during the second quarter worth $6,583,806,000. Corient Private Wealth LP acquired a new stake in Marsh & McLennan Companies during the 2nd quarter valued at approximately $66,475,000. Ninety One UK Ltd boosted its stake in shares of Marsh & McLennan Companies by 41.8% in the 3rd quarter. Ninety One UK Ltd now owns 5,632,700 shares of the financial services provider’s stock valued at $961,671,000 after purchasing an additional 1,661,178 shares during the last quarter. Deutsche Bank AG acquired a new stake in shares of Marsh & McLennan Companies during the second quarter worth $685,621,000. Finally, Bank of America Corp DE bought a new position in Marsh & McLennan Companies during the second quarter worth $575,845,000. Institutional investors own 87.99% of the company’s stock.

About Marsh & McLennan Companies

Marsh & McLennan Companies is a global professional services firm that provides advice and solutions in risk, strategy and people. The company serves businesses, governments and institutions through a portfolio of specialized businesses focused on insurance brokerage, reinsurance, consulting and talent management.

Its principal businesses include Marsh, an insurance brokerage and risk advisory firm; Guy Carpenter, a provider of reinsurance brokerage and related risk-management services; Mercer, which offers consulting in investment, retirement, health and workforce strategy; and Oliver Wyman, a management consulting firm serving clients across industries and regions.

Founded in 1905, Marsh & McLennan serves clients in countries and markets around the world.